BNC-105 drug page Clinical trials

Trials with BNC-105

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
90Planned patients

Showing 1–1 of 1

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer
Finished Phase 2 90 patients NCT03647839

This Phase II research project will test the efficacy, safety, and tolerability of an experimental drug combination: either nivolumab and BBI608 or nivolumab and BNC105 in patients with metastatic colorectal cancer who have previously fail…

Australia Sept 2018 – Apr 2021 Interventional
Combined with: BBI608